- SEK18.77bn
- SEK23.51bn
- SEK10.29bn
- 97
- 13
- 99
- 84
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 36.44 | ||
PEG Ratio (f) | 1.19 | ||
EPS Growth (f) | 44.02% | ||
Dividend Yield (f) | 0.81% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 3.54 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 23.52 | ||
Price to Sales | 1.82 | ||
EV to EBITDA | 15.27 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 7.3% | ||
Return on Equity | 4.91% | ||
Operating Margin | 7.01% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | SEKm | 5,273.3 | 7,992.6 | 9,084 | 9,685 | 10,286 | 10,762.75 | 11,380 | 24.21% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +268.27 | +30.83 | -34.66 | -50.9 | +24.93 | +57.35 | +24.12 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Directors
- Johan Sjo NEC (54)
- Kristina Willgard PRE (56)
- Martin Almgren CFO (45)
- Ove Sandin OTH (63)
- Peter Simonsbacka OTH (59)
- Stefan Hedelius DRC (52)
- Hakan Roos DRC (66)
- Andreas Gothberg IND (54)
- Eva Nilsagard IND (58)
- Birgit Norinder IND (73)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 15th, 2014
- Public Since
- March 16th, 2015
- No. of Shareholders
- 11,620
- No. of Employees
- 2,256
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange Stockholm
- Shares in Issue
- 121,864,061

- Address
- Brunkebergstorg 5, Box 3145, STOCKHOLM, 103 62
- Web
- https://www.add.life/
- Phone
- +46 842003830
- Contact
- Fredrik Dalborg
- Auditors
- KPMG AB
Upcoming Events for ALIF B
Q1 2025 AddLife AB Earnings Call
AddLife AB Annual Shareholders Meeting
Dividend For ALIFb.ST - 0.7500 SEK
Q2 2025 AddLife AB Earnings Release
Q2 2025 AddLife AB Earnings Call
Similar to ALIF B
Acarix AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
Arjo AB (publ)
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:04 UTC, shares in AddLife AB are trading at SEK154.00. This share price information is delayed by 15 minutes.
Shares in AddLife AB last closed at SEK154.00 and the price had moved by +57.3% over the past 365 days. In terms of relative price strength the AddLife AB share price has outperformed the FTSE Global All Cap Index by +54.53% over the past year.
The overall consensus recommendation for AddLife AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe AddLife AB dividend yield is 0.49% based on the trailing twelve month period.
Last year, AddLife AB paid a total dividend of SEK0.75, and it currently has a trailing dividend yield of 0.49%.Looking ahead, shares in AddLife AB are due to go ex-dividend on 2025-05-09 and the next dividend pay date is 2025-05-15.
AddLife AB are due to go ex-dividend on 2025-05-09 and the next dividend pay date is 2025-05-15. The historic dividend yield on AddLife AB shares is currently 0.49%.
To buy shares in AddLife AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK154.00, shares in AddLife AB had a market capitalisation of SEK18.77bn.
Here are the trading details for AddLife AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: ALIF B
Based on an overall assessment of its quality, value and momentum AddLife AB is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in AddLife AB is SEK172.00. That is 11.69% above the last closing price of SEK154.00.
Analysts covering AddLife AB currently have a consensus Earnings Per Share (EPS) forecast of SEK3.94 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AddLife AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -1.88%.
As of the last closing price of SEK154.00, shares in AddLife AB were trading +2.92% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The AddLife AB PE ratio based on its reported earnings over the past 12 months is 36.44. The shares last closed at SEK154.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
AddLife AB's management team is headed by:
- Johan Sjo - NEC
- Kristina Willgard - PRE
- Martin Almgren - CFO
- Ove Sandin - OTH
- Peter Simonsbacka - OTH
- Stefan Hedelius - DRC
- Hakan Roos - DRC
- Andreas Gothberg - IND
- Eva Nilsagard - IND
- Birgit Norinder - IND